View All Reports Email Us

Liquid Biopsy Market Research Report- Global Forecast to 2022 Liquid Biopsy Market Research Report- Global Forecast to 2022

  • ID: MRFR/HC/0239-HCRR
  • |
  • April, 2017
  • |
  • Region: Global
  • |
  • 85 pages
  • |
  • Half-Cooked Research Reports

Liquid Biopsy Market Information, by Therapeutic Area (Bladder Cancer, Lung Cancer, Brain Cancer, Melanoma, Breast Cancer, Non-Hodgkin Lymphoma), by Application (Cancer Drug Development, Device Development, Detection of Genetic Alterations in Tumors, cfDNA), by End Users (Pharmaceutical Companies, Hospital/Clinics, Reference Laboratories, Research Institutes and Others) - Forecast to 2022


Market Synopsis of Liquid Biopsy Market:


Market Scenario:
A test done on an sample of blood to search for cancer cells which forms a tumor that are circling in the blood or in bits of DNA from tumor cells that are in the blood. A liquid biopsy might be utilized to diagnose cancer at an early stage. It might likewise be utilized to arrange treatment or to discover how well the treatments are functioning or if cancer tumor have returned. Having the capacity to take various specimens of blood after some time may likewise help specialists comprehend what sort of molecular changes are occurring in a cancer tumor. Globally the market for liquid biopsy is expected to grow at the rate of about XX% from 2016 to 2022.


Liquid Biopsy Market, by Therapeutic Area


 


Study objectives of Liquid Biopsy Market:



  • To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the liquid biopsy market

  • To provide insights about factors affecting the market growth

  • To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective

  • To provide country level analysis of the market for segments by therapeutic area, by application, by end user and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global liquid biopsy market.


Intended Audience



  • Liquid biopsy market service providers

  • Biotechnology Companies

  • Research Institutes

  • Research and Development (R&D) Companies

  • Government Research Laboratories

  • Contract Research Organizations

  • Research and Consulting Companies

  • Liquid Biopsy Product Manufacturers and Distributors

  • Pharmaceutical Companies


Key Finding



  • The liquid biopsy North American market and is expected to reach $XX billion by 2022.

  • Brain cancer holds the largest share of XX% of the market.

  • Europe holds the second largest market share of XX% of liquid biopsy market and is projected to reach $XX billion by the end of forecast period.

  • Globally, Asia-Pacific the fastest growing region and expected to grow at the rate of XX% during the forecast period.


Segments:
Liquid biopsy market has been segmented on the basis of therapeutic area which comprises of Bladder cancer, Lung cancer, Brain cancer, Melanoma, Breast cancer, Non-Hodgkin lymphoma and others. On the basis of application the market is segmented into cancer drug development, device development, detection of genetic alterations in tumors, cfDNA and others. On the basis of end user, market is segmented into pharmaceutical companies, hospital/clinics, reference laboratories, research institutes and others.


Regional Analysis of Liquid biopsy market:
Globally North America is the largest market for liquid biopsy. Europe is the second-largest market. Furthermore Asia pacific market is expected to be the fastest growing market for liquid biopsy.


Key Players for Liquid biopsy market:
Some of the key players in this market are: Myriad Genetics, F. Hoffmann-La Roche Ltd, QIAGEN, Biocept Inc., Trovagene, Inc, Genomic Health, RainDance Technologies, Inc, Bio-Rad Laboratories, Inc., Janssen Global Services, LLC, and others.                                                                                                 


The report for Liquid Biopsy Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions

1    INTRODUCTION    

1.1    DEFINITION    

1.2    SCOPE OF STUDY    

1.2.1    RESEARCH OBJECTIVE    

1.2.2    ASSUMPTIONS & LIMITATIONS    

1.2.2.1    ASSUMPTIONS    

1.2.2.2    LIMITATIONS    

1.3    MARKET STRUCTURE:    



2    RESEARCH METHODOLOGY    

2.1    RESEARCH PROCESS:    

2.2    PRIMARY RESEARCH    

2.3    SECONDARY RESEARCH:

    

3    MARKET DYNAMICS    

3.1    DRIVERS    

3.2    RESTRAINTS        

3.3    OPPORTUNITIES    

3.4    MACROECONOMIC INDICATORS  

 

4    MARKET FACTOR ANALYSIS    

4.1    PORTERS FIVE FORCES MODEL    

4.2    BARGAINING POWER OF SUPPLIERS    

4.3    BARGAINING POWER OF BUYERS    

4.4    THREAT OF NEW ENTRANTS    

4.5    THREAT OF SUBSTITUTES    

4.6    INTENSITY OF RIVALRY    



5    GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC AREA    

5.1    BLADDER CANCER

5.2    LUNG CANCER

5.3    MELANOMA

5.4    BREAST CANCER

5.5    NON-HODGKIN LYMPHOMA

5.6    OTHERS



6.    GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION

6.1    DRUG DEVELOPMENT

6.2    DEVICE DEVELOPMENT

6.3    DETECTION OF GENETIC ALTERATIONS IN TUMORS

6.4    cfDNA

6.5    OTHERS



7.    GLOBAL LIQUID BIOPSYMARKET, BY END USER    

7.1    PHARMACEUTICAL COMPANIES

7.2    HOSPITAL /CLINIC    

7.3    REFERENCE LABORATORIES

7.4    RESEARCH INSTITUTES

7.5    OTHERS



8.    GLOBAL LIQUID BIOPSY MARKET, BY REGION    

8.1    AMERICA    

8.1.1    INTRODUCTION    

8.2    EUROPE    

8.2.1    INTRODUCTION    

8.3    ASIA-PACIFIC    

8.3.1    INTRODUCTION    

8.4    MIDDLE EAST & AFRICA    

8.4.1    INTRODUCTION  

 

9.    COMPETITIVE LANDSCAPE    

9.1    MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS    

9.1.1    STRATEGIC PARTNERSHIP    

9.1.2    MERGER & ACQUISITION    



10    COMPANY PROFILE    

10.1    MYRIAD GENETICS

10.1.1    OVERVIEW    

10.1.2    PRODUCT OVERVIEW    

10.1.3    FINANCIALS    

10.1.4    KEY DEVELOPMENTS    

10.2    F. HOFFMANN-LA ROCHE LTD    

10.2.1    OVERVIEW    

10.2.2    PRODUCT OVERVIEW    

10.2.3    FINANCIALS    

10.2.4    KEY DEVELOPMENTS    

10.3    QIAGEN

10.3.1    OVERVIEW

10.3.2    PRODUCT OVERVIEW    

10.3.3    FINANCIALS

10.3.4    KEY DEVELOPMENT        

10.4    BIOCEPT INC

10.4.1    OVERVIEW

10.4.2    PRODUCT OVERVIEW

10.4.3    FINANCIALS

10.4.4    KEY DEVELOPMENTS    

10.5    TROVAGENE, INC

10.5.1    OVERVIEW    

10.5.2    PRODUCT OVERVIEW    

10.5.3    FINANCIALS    

10.5.4    KEY DEVELOPMENTS    

10.6    OTHERS

List of Tables

TABLE 1    GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC ARE, 2013-2022 (USD MILLION)

TABLE 2    GLOBAL LIQUID BIOPSY MARKET, BY APPLICATION, 2013-2022 (USD MILLION)

TABLE 3        GLOBAL LIQUID BIOPSY MARKET, BY END USER, 2013-2022 (USD MILLION)

TABLE 4    GLOBAL LIQUID BIOPSY MARKET, BY REGION, 2013-2022 (USD MILLION)

List of Figures

FIGURE 1    RESEARCH PROCESS

FIGURE 2    PORTERS FIVE FORCES MODEL

FIGURE 3    GLOBAL LIQUID BIOPSY MARKET, BY THERAPEUTIC AREA

FIGURE 4    GLOBAL LIQUID BIOPSYMARKET, BY APPLICATION

FIGURE 5    GLOBAL LIQUID BIOPSY MARKET, BY END USER    

FIGURE 6    GLOBAL LIQUID BIOPSY MARKET, BY REGION

FIGURE 7    GLOBAL LIQUID BIOPSY MARKET: COMPANY SHARE ANALYSIS, 2015 (%)

 

captcha
Please enter code
captcha
Please enter code

Purchase this Market Research Report

Add To Cart

Market Research Videos

Related TAGS

Related Report

Related Categories

REPORT YOU MIGHT BE INTERESTED

Contact Us

Email Us at: salesteam@marketresearchfuture.com | Reach Us at: + (646) 845 9349 (US), +44 208 133 9349 (uk)